Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP450661.RA4ElU7c6O2H2B10YJJ5XF3cgDkFOY5mNrwn7oa3IifC8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP450661.RA4ElU7c6O2H2B10YJJ5XF3cgDkFOY5mNrwn7oa3IifC8130_assertion type Assertion NP450661.RA4ElU7c6O2H2B10YJJ5XF3cgDkFOY5mNrwn7oa3IifC8130_head.
- NP450661.RA4ElU7c6O2H2B10YJJ5XF3cgDkFOY5mNrwn7oa3IifC8130_assertion wasGeneratedBy ECO_0000203 NP450661.RA4ElU7c6O2H2B10YJJ5XF3cgDkFOY5mNrwn7oa3IifC8130_provenance.
- NP450661.RA4ElU7c6O2H2B10YJJ5XF3cgDkFOY5mNrwn7oa3IifC8130_assertion wasDerivedFrom befree-20150227 NP450661.RA4ElU7c6O2H2B10YJJ5XF3cgDkFOY5mNrwn7oa3IifC8130_provenance.
- NP450661.RA4ElU7c6O2H2B10YJJ5XF3cgDkFOY5mNrwn7oa3IifC8130_assertion SIO_000772 17602077 NP450661.RA4ElU7c6O2H2B10YJJ5XF3cgDkFOY5mNrwn7oa3IifC8130_provenance.
- NP450661.RA4ElU7c6O2H2B10YJJ5XF3cgDkFOY5mNrwn7oa3IifC8130_assertion evidence source_evidence_literature NP450661.RA4ElU7c6O2H2B10YJJ5XF3cgDkFOY5mNrwn7oa3IifC8130_provenance.
- NP450661.RA4ElU7c6O2H2B10YJJ5XF3cgDkFOY5mNrwn7oa3IifC8130_assertion description "[To evaluate the immunological and clinical response as well as the safety of the optimized peptide telomerase reverse transcriptase p572Y (TERT572Y) presented by HLA-A*0201 in patients with advanced non-small-cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450661.RA4ElU7c6O2H2B10YJJ5XF3cgDkFOY5mNrwn7oa3IifC8130_provenance.